Deepti Pandey

Deepti Pandey

Auto-generated profile, based on publicly available information

Deepti Pandey

Department of Pharmacy Universal College of Medical Sciences Bhairahawa Nepal

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2025 in Food Science & Nutrition
Verified
Journal Article
Open access
Shankar ThapaShankar Thapa
Shankar Thapa
DPDeepti Pandey
Deepti Pandey
MBMahalakshmi Suresha Biradar
Mahalakshmi Suresha Biradar
MAMonica Arora
Monica Arora
SVShithin Ann Varghese
Shithin Ann Varghese
BPBipindra Pandey
Bipindra Pandey
Diabetes is among the top ten causes of mortality and morbidity. Diabetes has been increasing faster in low‐ and middle‐income nations than it has been rising in high‐income countries. This study explores the phytochemical profiling and in vitro α‐amylase inhibitory activity of the methanolic extract of Nepalese‐origin pomegranate peels. Phytochemical analysis using FT‐IR and LC–MS identified key bioactive compounds, including ellagic acid, punicalagin, punicalin, gallic acid, and ellagic acid‐O‐xylopyranoside, contributing to the observed enzymatic inhibition. Molecular docking studies revealed strong binding affinities of punicalagin (−11.6 kcal/mol) and ellagic acid‐O‐xylopyranoside (−10.6 kcal/mol) to α‐amylase, suggesting potential antidiabetic properties. MD simulations confirmed the stability of these interactions over a 100 ns timeframe, reinforcing their role in enzyme inhibition. The in vitro α‐amylase inhibition assay demonstrated comparable activity of pomegranate peel extract (IC 50 = 137.74 μg/mL) to reference drug acarbose (IC 50 = 222.19 μg/mL). These findings provide molecular insights into the bioactivity of pomegranate peel extracts, highlighting their potential in diabetes management.